Vietnam-based Mekong Capital has named Nguyen Thi Minh Giang (pictured, third right) as a partner with responsibility for talent and culture. It brings the number of partners at the firm to four.
Nguyen joined Mekong in 2010 as a human resources officer, helping recruit leadership for former and existing investee companies. She went on to lead a team of four talent and culture specialists, which...
China-based data storage software services provider XSKY has raised a RMB320 million ($45 million) Series D led by China's State Owned Capital Venture Capital Fund.
CF PharmTech, a Chinese medical devices maker focused on innovative respiratory products, has raised a $50 million Series F round with support from CICC Capital.
Chinese insulin manufacturer Gan & Lee Pharmaceuticals, which counts Qiming Venture Partners and Goldman Sachs among its investors, raised RMB2.5 billion ($354 million) through an A-share IPO.
KKR has agreed to buy a 54% stake in Indian drug maker J.B. Chemicals & Pharmaceuticals for INR31.1 billion ($416 million) and made an open offer for an additional 26% of the company.